These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21536014)
61. Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain. Webster MK; Donoghue DJ Mol Cell Biol; 1997 Oct; 17(10):5739-47. PubMed ID: 9315632 [TBL] [Abstract][Full Text] [Related]
62. FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes. Hafner C; Di Martino E; Pitt E; Stempfl T; Tomlinson D; Hartmann A; Landthaler M; Knowles M; Vogt T Exp Cell Res; 2010 Jul; 316(12):2008-16. PubMed ID: 20420824 [TBL] [Abstract][Full Text] [Related]
63. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain. He L; Shobnam N; Hristova K Biochim Biophys Acta; 2011 Jan; 1808(1):253-9. PubMed ID: 20713021 [TBL] [Abstract][Full Text] [Related]
64. Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance. Javidi-Sharifi N; Traer E; Martinez J; Gupta A; Taguchi T; Dunlap J; Heinrich MC; Corless CL; Rubin BP; Druker BJ; Tyner JW Cancer Res; 2015 Mar; 75(5):880-91. PubMed ID: 25432174 [TBL] [Abstract][Full Text] [Related]
65. A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells. Salazar L; Kashiwada T; Krejci P; Muchowski P; Donoghue D; Wilcox WR; Thompson LM Hum Mol Genet; 2009 Jun; 18(11):1951-61. PubMed ID: 19286672 [TBL] [Abstract][Full Text] [Related]
66. Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family. Ajmal M; Mir A; Shoaib M; Malik SA; Nasir M Diagn Pathol; 2017 Jul; 12(1):47. PubMed ID: 28679403 [TBL] [Abstract][Full Text] [Related]
68. Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody. Yin Y; Ren X; Smith C; Guo Q; Malabunga M; Guernah I; Zhang Y; Shen J; Sun H; Chehab N; Loizos N; Ludwig DL; Ornitz DM Dis Model Mech; 2016 May; 9(5):563-71. PubMed ID: 27056048 [TBL] [Abstract][Full Text] [Related]
69. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor. Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810 [TBL] [Abstract][Full Text] [Related]
70. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1. Harada D; Yamanaka Y; Ueda K; Nishimura R; Morishima T; Seino Y; Tanaka H Bone; 2007 Aug; 41(2):273-81. PubMed ID: 17561467 [TBL] [Abstract][Full Text] [Related]
71. siRNA mediated knockdown of fibroblast growth factor receptors 1 or 3 inhibits FGF-induced anchorage-independent clonogenicity but does not affect MAPK activation. Estes NR; Thottassery JV; Kern FG Oncol Rep; 2006 Jun; 15(6):1407-16. PubMed ID: 16685373 [TBL] [Abstract][Full Text] [Related]
72. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Naski MC; Wang Q; Xu J; Ornitz DM Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234 [TBL] [Abstract][Full Text] [Related]
73. [Cytokines in bone diseases. FGF receptor signaling and achondroplasia/hypochondroplasia]. Tanaka H Clin Calcium; 2010 Oct; 20(10):1490-6. PubMed ID: 20890030 [TBL] [Abstract][Full Text] [Related]
74. Severe achondroplasia due to two de novo variants in the transmembrane domain of FGFR3 on the same allele: A case report. Nagata T; Matsushita M; Mishima K; Kamiya Y; Kato K; Toyama M; Ogi T; Ishiguro N; Kitoh H Mol Genet Genomic Med; 2020 Mar; 8(3):e1148. PubMed ID: 31975530 [TBL] [Abstract][Full Text] [Related]
75. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529. Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174 [TBL] [Abstract][Full Text] [Related]
76. In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia. Gonçalves D; Rignol G; Dellugat P; Hartmann G; Sarrazy Garcia S; Stavenhagen J; Santarelli L; Gouze E; Czech C PLoS One; 2020; 15(12):e0244368. PubMed ID: 33370388 [TBL] [Abstract][Full Text] [Related]
77. FGFR3 signaling and function in triple negative breast cancer. Chew NJ; Nguyen EV; Su SP; Novy K; Chan HC; Nguyen LK; Luu J; Simpson KJ; Lee RS; Daly RJ Cell Commun Signal; 2020 Jan; 18(1):13. PubMed ID: 31987043 [TBL] [Abstract][Full Text] [Related]